当前位置:首页 - 行情中心 - 葵花药业(002737) - 财务分析 - 现金流量表

葵花药业

(002737)

  

流通市值:66.75亿  总市值:66.75亿
流通股本:5.84亿   总股本:5.84亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,606,402,625.95846,012,773.563,088,389,815.961,558,594,617.29
  收到其他与经营活动有关的现金30,236,567.8513,581,283.77158,909,945.72128,347,590.48
  经营活动现金流入小计1,636,639,193.8859,594,057.333,247,299,761.681,686,942,207.77
  购买商品、接受劳务支付的现金563,385,696.6255,078,756.68842,071,176.85420,794,433.08
  支付给职工以及为职工支付的现金313,266,254.03145,994,897.4563,392,758.43440,849,607.04
  支付的各项税费140,384,186.8489,216,013.33232,575,591.01171,412,976.09
  支付其他与经营活动有关的现金594,055,086.02291,197,550.021,034,294,625.04433,561,199.36
  经营活动现金流出小计1,611,091,223.49781,487,217.432,672,334,151.331,466,618,215.57
  经营活动产生的现金流量净额25,547,970.3178,106,839.9574,965,610.35220,323,992.2
二、投资活动产生的现金流量:
  收回投资收到的现金4,758,414,0152,358,414,0159,317,544,0118,119,116,312.91
  取得投资收益收到的现金18,525,953.3211,469,388.6135,480,586.7631,198,234.44
  处置固定资产、无形资产和其他长期资产收回的现金净额137,70040,000524,714191,876
  投资活动现金流入小计4,777,077,668.322,369,923,403.619,353,549,311.768,150,506,423.35
  购建固定资产、无形资产和其他长期资产支付的现金51,349,478.2327,209,732.2396,103,588.2167,421,423.1
  投资支付的现金4,280,000,0001,800,000,0009,810,001,0008,360,000,000
  支付其他与投资活动有关的现金--62,937.89-
  投资活动现金流出小计4,331,349,478.231,827,209,732.239,906,167,526.18,427,421,423.1
  投资活动产生的现金流量净额445,728,190.09542,713,671.38-552,618,214.34-276,914,999.75
三、筹资活动产生的现金流量:
  取得借款收到的现金75,000,000-118,000,00018,000,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计75,000,000-118,000,00018,000,000
  偿还债务支付的现金--13,000,000-
  分配股利、利润或偿付利息支付的现金-603,750311,071,734.72310,506,399.09
  其中:子公司支付给少数股东的股利、利润--18,947,768.0518,947,768.05
  支付其他与筹资活动有关的现金2,203,522.781,783,556.124,122,924.063,501,536.72
  筹资活动现金流出小计2,203,522.782,387,306.12328,194,658.78314,007,935.81
  筹资活动产生的现金流量净额72,796,477.22-2,387,306.12-210,194,658.78-296,007,935.81
四、汇率变动对现金及现金等价物的影响-327,085.64-175,358.63-193,176.6665,213.33
五、现金及现金等价物净增加额543,745,551.98618,257,846.53-188,040,439.43-352,533,730.03
  加:期初现金及现金等价物余额849,920,259.08849,920,259.081,037,960,698.511,037,960,698.51
  期末现金及现金等价物余额1,393,665,811.061,468,178,105.61849,920,259.08685,426,968.48
补充资料:
  净利润85,479,307.67--297,073,301.51-
  资产减值准备34,587,404.31-77,428,515.19-
  固定资产和投资性房地产折旧60,792,457-141,708,886.19-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧60,792,457-141,708,886.19-
  无形资产摊销13,149,223.22-26,615,432.56-
  长期待摊费用摊销2,234,892.04-4,434,304.92-
  处置固定资产、无形资产和其他长期资产的损失140,134.19-654,459.15-
  固定资产报废损失--1,191,497.68-
  公允价值变动损失12,924,888.74--3,891,722.08-
  财务费用1,995,411.75-4,001,177.6-
  投资损失-15,716,642.36--31,048,755.67-
  递延所得税-149,043.57--28,463,731.21-
  其中:递延所得税资产减少650,187.36--26,523,568.09-
    递延所得税负债增加-799,230.93--1,940,163.12-
  存货的减少4,703,781.62-229,946,642.24-
  经营性应收项目的减少32,814,077.89-421,485,281.38-
  经营性应付项目的增加-209,874,693.87-23,144,120.09-
  现金的期末余额1,393,665,811.06-849,920,259.08-
  减:现金的期初余额849,920,259.08-1,037,960,698.51-
  现金及现金等价物的净增加额543,745,551.98--188,040,439.43-
公告日期2026-08-292026-04-302026-04-272025-10-28
审计意见(境内)标准无保留意见
TOP↑